Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
U.S. Physical Therapy Acquires Nine-Clinic Physical Therapy And Hand Therapy Practice
U.S. Physical Therapy, Inc., a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced on April 1 the acquisition of a physical therapy and hand therapy practice with nine clinic locations. The practice being acquired currently generates approximately $11.4 million in annual revenues and has approximately 65,000 annual visits, according to the original deal press release published on BusinessWire on April 1, 2024. Founded in 1990, U.S. Physical Therapy, Inc. operates more than 678 outpatient physical therapy clinics in 42 states. The company’s clinics provide preventive and post-operative care for a variety of... Read More »
First Quarter 2024 Healthcare M&A Results
Overview When we spoke to advisors and analysts in 2023, they all expected “more of the same” for the healthcare M&A market in 2024. None of the headwinds from 2023 were expected to be resolved this year, and especially not by the first quarter. In mid-March, the Federal Reserve (again) declined to adjust interest rates, remaining at 5.25% to 5.5%. The Biden Administration and Federal Regulators remain skeptical of private equity investments in the healthcare and senior care markets and pledged to continue reviewing their activity throughout the year, challenging deals and mergers. Labor shortages continue to pressure healthcare organizations and providers. Hospitals have been hit... Read More »
Labcorp Acquires Select Assets of BioReference Health’s Diagnostics Business
Labcorp and OPKO Health announced on March 28 that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO Health. Through this transaction, Labcorp will acquire BioReference Health’s laboratory testing businesses focused on clinical diagnostics and reproductive and women’s health across the United States outside of New York and New Jersey. Also included are BioReference’s patient service centers and certain customer contracts and operating assets. The assets being acquired currently generate approximately $100 million in annual revenue, according to the original deal press release from March 28,... Read More »
Acadia Healthcare Acquires Three Comprehensive Treatment Centers in North Carolina
Acadia Healthcare Company, Inc. announced on March 28 that it has recently completed the acquisitions of three comprehensive treatment centers (CTC) in North Carolina. The CTCs are located in Raleigh, Greenville and Hillsborough, North Carolina. Acadia is a leading provider of behavioral healthcare services across the United States. As of December 31, 2023, Acadia operated a network of 253 behavioral healthcare facilities with approximately 11,200 beds in 38 states and Puerto Rico. With more than 20,000 employees serving approximately 70,000 patients daily, Acadia is the largest stand-alone behavioral health company in the United States. According to its FY 2023 financial report, Acadia... Read More »
Highbridge Capital Management Acquires Gamida Cell for $70 Million
Highbridge Capital Management, based in New York City, announced on March 27 that it entered into an agreement to acquire Gamida Cell, an Israeli biotechnology company. The agreement will see Highbridge Capital Management convert $75 million of existing unsecured convertible senior notes into equity in Gamida as well as supply $30 million of new capital to Gamida. Gamida Cell is a cell therapy pioneer working to turn cells into powerful therapeutics. Its proprietary nicotinamide technology expands the number of cells while maintaining their intrinsic properties to create potentially curative cell therapy products and candidates for patients with cancer. Gamida entered 2024... Read More »
American Oncology Network Partners With Woodlands Cancer Institute
The American Oncology Network (AON) announced on March 26 the addition of Woodlands Cancer Institute and its physicians to its network. Woodlands Cancer Institute is AON’s second practice in Texas and first in Montgomery County. Headquartered in The Woodlands, Texas, Woodlands Cancer Institute is a community-based radiation oncology and hematology practice providing treatment for patients diagnosed with all types of cancer and blood disorders. According to its website, the practice has four providers and one advanced practitioner on staff. AON is an alliance of physicians and healthcare leaders partnering to ensure the long-term success of community oncology. Founded in 2018, AON’s... Read More »
Eisenhower Health Purchases Neuro Vitality Center
Rancho Mirage, California-based Eisenhower Health announced that it has purchased the Neuro Vitality Center in California. Neuro Vitality Center, formerly the Stroke Recovery Center, is a medical clinic that has served neurologically challenged and chronically ill patients in the Palm Springs, California community since 1978. In partnership with Los Angeles Jewish Health, Eisenhower will provide a Program of All-Inclusive Care for the Elderly (PACE) at the former Neuro Vitality Center location. Eisenhower Health is a not-for-profit, comprehensive healthcare institution that includes the 437-bed Eisenhower Hospital, the Barbara Sinatra Children’s Center at Eisenhower and the Annenberg... Read More »
StatLab Medical Products Acquires Poly Scientific R&D
McKinney, Texas-based StatLab Medical Products announced that it has acquired Poly Scientific R&D. Poly Scientific is one of the leading manufacturers of chemicals, stains and reagents for histology, cytology and microbiology, as well as other items for in-vitro diagnostic testing. The company was founded in 1969 and is based in Bay Shore, New York. StatLab Medical Products, an Audax Private Equity and Linden Capital Partners portfolio company, is a McKinney, Texas-based developer and manufacturer of histology, cytology and immunohistochemistry diagnostic products. The company partners with anatomic pathology laboratories to provide easy access to more than 3,500... Read More »
Juvisé Pharmaceuticals Purchases Global Rights to PONVORY
On March 26, Juvisé Pharmaceuticals announced that it entered into an agreement to acquire the global rights to PONVORY from Actelion Pharmaceuticals, a Johnson & Johnson company. These global rights exclude the rights to United States and Canada. Ponvory is indicated for the treatment of adults with active forms of relapsing multiple sclerosis; it is protected by several patents, the latest of which expires in 2035. Founded in 2008, Juvise Pharmaceuticals is an international pharmaceutical company based in Villeurbanne, France. Juvisé re-prioritized essential medicines in oncology (breast and prostate cancer), cardiology, gastroenterology, neuropsychiatry and rheumatology,... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
